Circulating EPAC1 concentrations were significantly lower in the CAD group compared to the non-CAD group (9.41 ± 4.00 vs 11.97 ± 3.30 ng/mL, p < 0.001). This evidence concerns the gene RAPGEF3 and coronary artery disorder.